IGF2 and breast carcinoma: For example, it has been reported that breast cancer-secreted miR-122 reprograms glucose metabolism to promote metastasis (20); meanwhile, it has been illustrated that cancer cell-secreted IGF2 instigates fibroblasts and bone marrow-derived vascular progenitor cells to promote cancer progression (21).